Dublin, Nov. 30, 2017 -- The "Veterinary Drugs Market: Global Industry Analysis, Trends, Market Size & Forecasts to 2023" report has been added to Research and Markets' offering.
The report predicts the global Veterinary Drugs market to grow with a CAGR between 5.0 % and 5.5 % from 2017 to 2023. The global Veterinary Drugs market was worth USD 18.07 Billion in 2016. The study on Veterinary Drugs market covers the analysis of regions such as North America, Europe, Asia Pacific, and Rest of the World. Among the geographies North America dominated the world market and Asia Pacific anticipated growing at the highest CAGR over the forecast period.
The report on global Veterinary Drugs market is a comprehensive study of demand, market size, forecasts, trends and factors affecting the global Veterinary Drugs market. Moreover, the report is collective presentation of primary and secondary research findings. In addition, it provides deep insights on the factors that driving, restraining the global Veterinary Drugs market. Porter's five forces model in the report provides insights into the competitive rivalry in the global Veterinary Drugs market over the period of 2017-2023. Further, the Growth Matrix given in the report brings an insight on the investment areas that existing or new market players can consider.
Report Findings
1. Drivers
- Epidemics disorder in animal.
- Introduction of advanced and cost effective veterinary drugs.
- Rising clinical animal researches to treat disease and disorders in animal
2. Restraints
- Complex complications involved in the diseases of animal.
3. Opportunities
- Rising research and development investment in order to develop more effective drugs
- Rising meat consumption across the globe.
Segments Covered
1. Global Veterinary Drugs market
a. By drug type
- Anti-Infective
- Anti-Inflammatory
- Parasiticides
b. By Route of Administration
- Oral
- Parenteral
- Topical
c. By Animal Type
- Companion Animal
- Livestock Animal
2. Global Veterinary Drugs market by Region
a. North America
b. Europe
c. Asia Pacific
d. Row
Companies Profiled:
- Boehringer Ingelheim GmbH
- Bayer AG
- Elanco Animal Health (Eli Lilly and Company)
- Ceva Sant Animale
- Dechra Pharmaceuticals PLC.
- Merck Animal Health
- Virbac
- Vetoquinol
Key Topics Covered:
1. Preface
1.1 Report Description
1.2 Research Methods
1.3 Research Approaches
2. Executive Summary
3. Global Veterinary Drugs Market Overview
3.1 Introduction
3.2 Market Dynamics
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunities
3.2.4 Challenges
3.3 Porter's Five Forces Analysis
3.4 Growth Matrix Analysis
3.5 Competitive Landscape in the Veterinary Drugs Market
4. Global Veterinary Drugs Market: Snapshots
4.1 Global Veterinary Drugs Market key trends
4.2 Global Veterinary Drugs Market by Drug type
4.3 Global Veterinary Drugs Market by Route of Administration
4.4 Global Veterinary Drugs Market by Animal type
4.5 Global Veterinary Drugs Market by Region
5. Global Veterinary Drugs by Drug type (USD Billion) 2017-2023
5.1 Anti-Infectives
5.2 Anti-Inflammatory
5.3 Parasiticides
5.4 Others
6. Global Veterinary Drugs Market Analysis, by Route Of Administration (USD Billion) 2017-2023
6.1 Oral
6.2 Parenteral
6.3 Topical
7. Global Veterinary Drugs Market Analysis, by Animal Type (USD Billion) 2017-2023
7.1 Companion Animal
7.2 Livestock Animal
8. Global Veterinary Drugs Market Analysis, by Region (USD Billion) 2017-2023
8.1 North America
8.2 Europe
8.3 Asia Pacific
8.4 RoW
9. Company Profiles
9.1 Boehringer Ingelheim GmbH
9.2 Bayer AG
9.3 Elanco Animal Health (Eli Lilly and Company)
9.4 Ceva Sant Animale
9.5 Dechra Pharmaceuticals PLC.
9.6 Merck Animal Health
9.7 Virbac
9.8 Vetoquinol
For more information about this report visit https://www.researchandmarkets.com/research/qcm6nb/veterinary_drugs
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Animal Healthcare/Veterinary


Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Washington Post Publisher Will Lewis Steps Down After Layoffs
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Anta Sports Expands Global Footprint With Strategic Puma Stake
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 



